VGT-309

· Vergent Bioscience, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for VGT-309, covering 2024-10-17 to 2026-04-08. Get the full timeline:

Most recent: Clinical Trial Update: Fluorescent Probe VGT-309 to ID Cancerous Colorectal Lesions During Augmented Colonoscopy [EARLY_Phase 1]